Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 9268 mesalazin - rektální suspenze - 1g - mesalazin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 9268 mesalazin - Čípek - 1g - mesalazin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 9268 mesalazin - tableta s prodlouženým uvolňováním - 1g - mesalazin

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ferring-léčiva, a.s., jesenice u prahy array - 9268 mesalazin - tableta s prodlouženým uvolňováním - 500mg - mesalazin

USA - engelsk - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - mesalamine (unii: 4q81i59gxc) (mesalamine - unii:4q81i59gxc) - mesalamine 250 mg - pentasa is indicated for the induction of remission and for the treatment of adult patients with mildly to moderately active ulcerative colitis. pentasa is contraindicated in patients with known or suspected hypersensitivity to salicylates, aminosalicylates, or any components of this medication.

USA - engelsk - NLM (National Library of Medicine)

avera mckennan hospital - mesalamine (unii: 4q81i59gxc) (mesalamine - unii:4q81i59gxc) - mesalamine 250 mg - pentasa is indicated for the induction of remission and for the treatment of patients with mildly to moderately active ulcerative colitis. pentasa is contraindicated in patients who have demonstrated hypersensitivity to mesalamine, any other components of this medication, or salicylates.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - mesalazine, quantity: 1 g - tablet, modified release - excipient ingredients: magnesium stearate; purified talc; ethylcellulose; povidone; microcrystalline cellulose - treatment of mild to moderate ulcerative colitis and crohn's disease and maintenance of remission.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - mesalazine, quantity: 500 mg - tablet, modified release - excipient ingredients: purified talc; ethylcellulose; povidone; microcrystalline cellulose; magnesium stearate - treatment of mild to moderate ulcerative colitis and crohn's disease and maintenance of remission.

Serbia - serbisk - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

ferring pharmaceuticals d.o.o. beograd-stari grad - месалазин - granule sa produženim oslobađanjem - 2g

Serbia - serbisk - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

ferring pharmaceuticals d.o.o. beograd-stari grad - месалазин - granule sa produženim oslobađanjem - 4g